Back to search

Article

Metformin, empagliflozin and their combination modulate ex-vivo macrophage inflammatory gene expression

2022-06-20

Abstract excerpt

Type-2 Diabetes Mellitus is a complex, chronic illness characterized by persistent high blood glucose levels. Patients can be prescribed anti-diabetes drugs as single agents or in combination depending on the severity of their condition. Metformin and empagliflozin are two commonly prescribed anti-diabetes drugs which reduce hyperglycemia, however their direct effects on macrophage inflammatory responses alone or...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a070dd03-a08c-52ea-8832-43483dfd058d
DOI
10.1101/2022.06.20.496771
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metformin, empagliflozin and their combination modulate ex-vivo macrophage inflammatory gene expressionDOI 10.1101/2022.06.20.496771
Select a neighboring publication to make it the new centre.